Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)

KRW 5320.0

(1.92%)

Market Cap (In KRW)

121.64 Billion

Revenue (In KRW)

88.59 Billion

Net Income (In KRW)

-2.07 Billion

Avg. Volume

47.39 Thousand

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4150.0-6000.0
PE
-
EPS
0.0
Beta Value
0.48
ISIN
KR7002210003
CUSIP
-
CIK
-
Shares
22866018.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yang-Gu Lee
Employee Count
-
Website
https://dongsung-pharm.com
Ipo Date
2000-01-04
Details
Dong Sung Bio Pharm.Co.,Ltd. engages in the pharmaceuticals, cosmetics, hair dye, and photodynamic therapy businesses in South Korea. It offers OTC drugs, such as liver disease treatment, climacterium, skin disease, obesity, digestive, gingival, alopecia, antipyretic, analgesic, anti-inflammatory, respiratory, scar-recovery, sleep inducer, antidiarrhotica, antiemetic, antiviral, blood circulation enhancer, antifungal, and anti-histamine drugs, as well as keratin softeners, optic nutrition supplements, and vitamins. The company also provides ETC drugs, including endocrine, gastrointestinal, circulatory, neuropsychologic, tumor, analgesic/anti-inflammation, dermato-urinary, anti-viral, antibiotic, antifungal, anti-histamine, and respiratory drugs, as well as steroids and eye drops. In addition, it offers hair dyeing agents, health functional foods, medical devices, daily supplies, muscle taping products, disinfectants, toothpastes, anti-hair loss and hair increase shampoos, sanitary pads, and other products. The company was founded in 1957 and is headquartered in Seoul, South Korea.